Emergent BioSolutions Inc. Contracts & Agreements

257 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Emergent BioSolutions Inc. Amended and Restated Stock Incentive Plan
Bonus & Incentive Agreements
Emergent BioSolutions Inc.
2024
Emergent BioSolutions Inc. Inducement Plan
Emergent BioSolutions Inc.
2023
Form of Letter Agreement, dated July 26, 2023
Emergent BioSolutions Inc.
2023
Modification No. 28, effective April 14, 2022, to the CDC BioThrax Procurement Contract
Modification Agreements
Emergent BioSolutions Inc.
2022
Modification No. 29, effective June 16, 2022, to the CDC BioThrax Procurement Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 27, effective March 31, 2022, to the Solicitation/Contract/Order for Commercial Items (the CDC BioThrax Procurement Contract), effective December 8, 2016, from...
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Consulting Agreement, dated as of March 18, 2022 and effective as of April 1, 2022, by and between Emergent BioSolutions Inc. and Fuad El-Hibri
Consulting Agreements
Emergent BioSolutions Inc.
2022
Agreement to Terminate Class A Stockholders Registration Rights Agreement, dated December 9, 2021 by and among Emergent BioSolutions Inc., Intervac, L.L.C. and BioVac, L.L.C
Registration Rights Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 26, effective November 1, 2021, to the CDC BioThrax Procurement Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 1
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 4, effective, July 13, 2021 to the ACAM2000 Contract
Modification Agreements
Emergent BioSolutions Inc.
2022
Modification No. 5, effective, September 29, 2021 to the ACAM2000 Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 6, effective, November 1, 2021 to the ACAM2000 Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 3, effective
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 4, effective
Modification Agreements
Emergent BioSolutions Inc.
2022
Modification No. 8, effective
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 31, effective October 20, 2021, to the BARDA ADM Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 32, effective November 1, 2021, to the BARDA ADM Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Award/Contract (the BARDA AV7909 Contract), effective September 30, 2016, from the BioMedical Advanced Research and Development Authority to Emergent Product Development...
Development Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 1, effective March 16 2017, to the BARDA AV7909 Contract
Modification Agreements
Emergent BioSolutions Inc.
2021
Modification No. 2, effective August 29, 2018, to the BARDA AV7909 Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 11, effective September 30, 2021, to the BARDA AV7909 Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 24, effective February 2, 2021, to the Solicitation/Contract/Order for Commercial Items, effective December 8, 2016, from the Centers for Disease Control and...
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 25, effective September 29, 2021, to the CDC BioThrax Procurement Contract
Modification Agreements
Emergent BioSolutions Inc.
2021
Modification No. 30, effective September 30, 2021, to the Award/Contract, effective June 15, 2012 (the BARDA ADM Contract), from the BioMedical Advance Research and Development...
Development Agreements
Emergent BioSolutions Inc.
2021
The CDC BioThrax Procurement Contract, effective December 8, 2016
Emergent BioSolutions Inc.
2021
Modification No. 7, effective December 2, 2020, to the Award/Contract, effective September 30, 2016, from the BioMedical Advanced Research and Development Authority to Emergent...
Development Agreements
Emergent BioSolutions Inc.
2021
Modification No. 8, effective March 22, 2021, to the BARDA AV7909 Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 9, effective April 21, 2021, to the BARDA AV7909 Contract
Modification Agreements
Emergent BioSolutions Inc.
2021
Modification No. 10, effective June 10, 2021 to the BARDA AV7909 Contract
Modification Agreements
Emergent BioSolutions Inc.
2021
Modification No. 3, effective, April 1, 2021, to the Award/Contract, effective August 30, 2019 (ACAM2000 Contract), from the Assistant Secretary, U.S. Department of Health and...
Development Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 27, effective May 6, 2021, to the Award/Contract, effective June 15, 2012 (the BARDA ADM Contract), from the BioMedical Advance Research and Development Authority...
Development Agreements
Emergent BioSolutions Inc.
2021
Modification No. 28, effective May 27, 2021, to the BARDA ADM Contract
Modification Agreements
Emergent BioSolutions Inc.
2021
Order for Supplies and Services Between Emergent Manufacturing Operations Baltimore LLC and the BioMedical Advance Research and Development Authority, dated
Development Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 1, effective
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 7, effective May 24, 2021, to Order for Supplies and Services Between Emergent Manufacturing Operations Baltimore LLC and the BioMedical Advance Research and...
Development Agreements
Emergent BioSolutions Inc.
2021
Change Order No
Emergent BioSolutions Inc.
2021
Change Order No
Emergent BioSolutions Inc.
Biotechnology
2021
Change Order No. 4 to Work Order #5997-01, effective
Emergent BioSolutions Inc.
Biotechnology
2021
Change Order No
Emergent BioSolutions Inc.
2021
Change Order No. 6 to Work Order #5997-01, effective
Emergent BioSolutions Inc.
2021
Change Order No
Emergent BioSolutions Inc.
2021
Change Order No
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 4, effective January 29, 2021, to Order for Supplies and Services Between Emergent Manufacturing Operations Baltimore LLC and the BioMedical Advance Research and...
Development Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 5, effective February 22, 2021, to Task Order 75A50120F33007
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 6, effective March 24, 2021, to Task Order 75A50120F33007
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Amendment No. 1, effective February 25, 2021, to Manufacturing Services Agreement, dated July
Services Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Amendment No
Emergent BioSolutions Inc.
Biotechnology
2021
Amendment No. 3, effective November 25, 2020, to AZ MSA
Emergent BioSolutions Inc.
2021
Amendment No. 4, effective January 21, 2021, to AZ MSA
Emergent BioSolutions Inc.
2021
Description of the Company's Securities
Emergent BioSolutions Inc.
Biotechnology
2021
Global Form of Restricted Stock Unit Award Agreement
Stock Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 2
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 2
Modification Agreements
Emergent BioSolutions Inc.
2021
Modification No. 23, effective September 30, 2020, to the CDC BioThrax Procurement Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 2, effective, October 28, 2020 to the ACAM 2000 Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 2, effective September 18, 2020, to Task Order 75A50120F33007
Modification Agreements
Emergent BioSolutions Inc.
2021
Modification No. 3, effective October 7, 2020, to Task Order 75A50120F33007
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 2, effective November 17, 2020, to Task Order 75A50120F33008
Modification Agreements
Emergent BioSolutions Inc.
2021
Modification No. 26, effective November 2, 2020 to the BARDA ADM Contract
Modification Agreements
Emergent BioSolutions Inc.
2021
Modification No. 6, effective July 13, 2020, to the Award/Contract, effective September 30, 2016, from the BioMedical Advanced Research and Development Authority to Emergent...
Development Agreements
Emergent BioSolutions Inc.
Biotechnology
2020
Modification No. 21, effective June 12, 2020, to the Award/Contract, effective June 15, 2012 (the BARDA ADM Contract), from the BioMedical Advance Research and Development...
Development Agreements
Emergent BioSolutions Inc.
Biotechnology
2020
Modification No. 22, effective June 12, 2020, to the BARDA ADM Contract
Modification Agreements
Emergent BioSolutions Inc.
2020
Modification No. 23, effective July 22, 2020, to the BARDA ADM Contract
Modification Agreements
Emergent BioSolutions Inc.
2020
Modification No. 24, effective August 28, 2020, to the BARDA ADM Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2020
Modification No. 25, effective September 25, 2020, to the BARDA ADM Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2020
Modification No. 1, effective August 24, 2020, to task order #75A50120F33007, between Emergent Manufacturing Operations Baltimore LLC and the BioMedical Advance Research and...
Development Agreements
Emergent BioSolutions Inc.
2020
Order for Supplies and Services Between Emergent Manufacturing Operations Baltimore LLC and the BioMedical Advance Research and Development Authority, dated August 6, 2020, under...
Development Agreements
Emergent BioSolutions Inc.
2020
Modification No. 1, effective August 24, 2020, to
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2020
Manufacturing Services Agreement, dated July 26, 2020, by and between Emergent Manufacturing Operations Baltimore, LLC and AstraZeneca Pharmaceuticals LP. (AZ MSA)
Services Agreements
Emergent BioSolutions Inc.
Biotechnology
DE
2020
Manufacturing Product Schedule, dated July 26, 2020 to AZ MSA
Emergent BioSolutions Inc.
Biotechnology
2020
Work Order to Manufacturing Services Agreement, dated June 10, 2020, between Emergent Manufacturing Operations Baltimore, LLC and AstraZeneca Pharmaceuticals LP (included as part...
Services Agreements
Emergent BioSolutions Inc.
2020
Amendment No. 1, effective September 30, 2020, to AZ MSA
Emergent BioSolutions Inc.
2020
Manufacturing Services Agreement, dated July 2, 2020, by and between Emergent Manufacturing Operations Baltimore, LLC and Janssen Pharmaceuticals, Inc., one of the Janssen...
Services Agreements
Emergent BioSolutions Inc.
2020
Indenture, dated as of August 7, 2020, by and among the Company, certain subsidiaries of the Company and U.S. Bank National Association, as trustee
Indenture Agreements
Emergent BioSolutions Inc.
2020
Purchase Agreement, dated as of August 4, 2020, by and among the Company, the subsidiaries of the Company named therein as guarantors, and Wells Fargo Securities, LLC, as...
Purchase Agreements
Emergent BioSolutions Inc.
Biotechnology
DE
2020
Second Amendment to Amended and Restated Credit Agreement, dated August 7, 2020
Credit Agreements
Emergent BioSolutions Inc.
Biotechnology
NY
2020
Indenture, dated as of August 7, 2020, by and among the Company, certain subsidiaries of the Company and U.S. Bank National Association, as trustee
Indenture Agreements
Emergent BioSolutions Inc.
2020
Purchase Agreement, dated as of August 4, 2020, by and among the Company, the subsidiaries of the Company named therein as guarantors, and Wells Fargo Securities, LLC, as...
Purchase Agreements
Emergent BioSolutions Inc.
2020
Second Amendment to Amended and Restated Credit Agreement, dated August 7, 2020
Credit Agreements
Emergent BioSolutions Inc.
Biotechnology
NY
2020
Award/Contract, effective June 15, 2012 (BARDA ADM Contract), from the BioMedical Advance Research and Development Authority to Emergent Manufacturing Operations Baltimore LLC
Development Agreements
Emergent BioSolutions Inc.
2020
Modification No. 19, effective, May 25, 2020, to the BARDA ADM Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2020
Modification No. 20, effective, May 26, 2020, to the BARDA ADM Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2020
Order for Supplies and Services Between Emergent Manufacturing Operations Baltimore LLC and the BioMedical Advance Research and Development Authority, dated May 24, 2020, under...
Development Agreements
Emergent BioSolutions Inc.
Biotechnology
2020
Modification No. 1, effective, May 28, 2020 to the Award/Contract, effective August 30, 2019 (ACAM2000 Contract), from the Assistant Secretary, U.S. Department of Health and Human...
Development Agreements
Emergent BioSolutions Inc.
Biotechnology
2020
Modification #No. 4, effective March 3, 2020, to the Award/Contract, effective September 30, 2016, from the BioMedical Advanced Research and Development Authority to Emergent...
Development Agreements
Emergent BioSolutions Inc.
2020
Modification #No. 5, effective April 10, 2020, to the BARDA AV7909 Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2020
Description of the Company's Securities
Emergent BioSolutions Inc.
2020
Global Form of Restricted Stock Unit Award Agreement
Stock Agreements
Emergent BioSolutions Inc.
2020
Global Form of Non-Qualified Stock Option Agreement
Stock Agreements
Emergent BioSolutions Inc.
2020
Modification No. 18, effective September 11, 2019, to the CDC BioThrax Procurement Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2020
Modification No. 19, effective January 6, 2020, to the CDC BioThrax Procurement Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2020
Award/Contract (the BARDA AV7909 Contract), effective September 30, 2016, from the BioMedical Advanced Research and Development Authority to Emergent Product Development...
Development Agreements
Emergent BioSolutions Inc.
Biotechnology
2020
Award/Contract, effective August 30, 2019 (ACAM 2000 Contract), from the Assistant Secretary, U.S. Department of Health and Human Services (ASPR/OPM) to Emergent Product...
Development Agreements
Emergent BioSolutions Inc.
2020
Modification #3, effective July 30, 2019, to the Award/Contract, effective September 30, 2016, from the BioMedical Advanced Research and Development Authority to Emergent Product...
Development Agreements
Emergent BioSolutions Inc.
Biotechnology
2019
Notice of Award Letter, dated August 30, 2019, from the Department of Health and Human Services to Emergent Product Development Gaithersburg, Inc. awarding Contract 75A50119C00052...
Development Agreements
Emergent BioSolutions Inc.
Biotechnology
2019
Modification No. 17, effective June 13, 2019, to the Solicitation/Contract/Order for Commercial Items, effective December 8, 2016, from the Centers for Disease Control and...
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2019
First Amendment, dated June 27, 2019, to Amended and Restated Credit Agreement, dated October 15, 2018, by and among Emergent BioSolutions Inc., the lenders party thereto from...
Credit Agreements
Emergent BioSolutions Inc.
2019
Amendment No. 2 to License Agreement, dated as of December 15, 2014, by and between Opiant Pharmaceuticals, Inc. (formerly known as Lightlake Therapeutics Inc.) and Adapt Pharma...
License Agreements
Emergent BioSolutions Inc.
Biotechnology
2019
Emergent BioSolutions Inc. Form of Director Nonstatutory Stock Option Agreement
Stock Agreements
Emergent BioSolutions Inc.
2019
EMERGENT BIOSOLUTIONS INC. Form of Director Restricted Stock Unit Agreement
Stock Agreements
Emergent BioSolutions Inc.
Biotechnology
DE
2019
Emergent BioSolutions Inc. Non-Qualified Stock Option Award Agreement
Stock Agreements
Emergent BioSolutions Inc.
2019
Emergent BioSolutions Inc. Form of Restricted Stock Unit Award Agreement
Stock Agreements
Emergent BioSolutions Inc.
2019
Emergent BioSolutions Inc. Non-Qualified Stock Option Award Agreement Canadian Participant
Stock Agreements
Emergent BioSolutions Inc.
2019
Emergent BioSolutions Inc. Form of Restricted Stock Unit Award Agreement Canadian Participant
Stock Agreements
Emergent BioSolutions Inc.
Biotechnology
DE
2019
Emergent BioSolutions Inc. Non-Qualified UK Stock Option Award Agreement UK Participant
Stock Agreements
Emergent BioSolutions Inc.
Biotechnology
2019
Emergent BioSolutions Inc. Form of UK Restricted Stock Unit Award Agreement UK Participant
Stock Agreements
Emergent BioSolutions Inc.
Biotechnology
DE
2019
Emergent BioSolutions Inc. Non-Qualified Stock Option Award Agreement Swiss Participant
Stock Agreements
Emergent BioSolutions Inc.
Biotechnology
2019
Emergent BioSolutions Inc. Form of Restricted Stock Unit Award Agreement Swiss Participant
Stock Agreements
Emergent BioSolutions Inc.
2019
Emergent BioSolutions Inc. Non-Qualified Stock Option Award Agreement Irish Participant
Stock Agreements
Emergent BioSolutions Inc.
2019
Emergent BioSolutions Inc. Form of Restricted Stock Unit Award Agreement Irish Participant
Stock Agreements
Emergent BioSolutions Inc.
Biotechnology
DE
2019
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
Emergent BioSolutions Inc.
Biotechnology
2019
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
Emergent BioSolutions Inc.
2019
PAGE OF PAGES
Emergent BioSolutions Inc.
Biotechnology
2019
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
Emergent BioSolutions Inc.
2019
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
Emergent BioSolutions Inc.
2019
Modification No. 13, effective September 21, 2018, to the Solicitation/Contract/Order for Commercial Items, effective December 8, 2016, from the Centers for Disease Control and...
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2018
Modification No. 2, effective August 29, 2018 to the Award/Contract, effective September 30, 2016, from the BioMedical Advanced Research and Development Authority to Emergent...
Development Agreements
Emergent BioSolutions Inc.
Biotechnology
2018
Merger Agreement, dated August 8, 2018, among Emergent, PaxVax, Merger Sub and the Shareholder Representative
Merger Agreements
Emergent BioSolutions Inc.
2018
Commitment Letter, dated August 28, 2018
Emergent BioSolutions Inc.
2018
Modification No. 10, effective June 18, 2018, to the CDC BioThrax Procurement Contract
Modification Agreements
Emergent BioSolutions Inc.
2018
Modification No. 11, effective June 20, 2018, to the CDC BioThrax Procurement Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2018
Modification No. 12, effective June 21, 2018, to the CDC BioThrax Procurement Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2018
Modification No. 7, effective February 26, 2018, to the Solicitation/Contract/Order for Commercial Items, effective December 8, 2016, from the Centers for Disease Control and...
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2018
Modification No. 8, effective March 6, 2018, to the CDC BioThrax Procurement Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2018
Form of Director Restricted Stock Unit Agreement
Stock Agreements
Emergent BioSolutions Inc.
2018
Form of Restricted Stock Unit Agreement
Stock Agreements
Emergent BioSolutions Inc.
Biotechnology
DE
2018
Form of Restricted Stock Unit Award Agreement
Stock Agreements
Emergent BioSolutions Inc.
Biotechnology
DE
2018
Modification No. 1
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2018
Modification No. 4
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2018
Modification No. 6
Modification Agreements
Emergent BioSolutions Inc.
2018
Modification No. 5, effective September 8, 2017, to the Solicitation/Contract/Order for Commercial Items (the "CDC BioThrax Procurement Contract"), effective December 8, 2016,...
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2017
SIXTH AMENDMENT TO CREDIT AGREEMENT
Credit Agreements
Emergent BioSolutions Inc.
Biotechnology
NY
2017
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
Emergent BioSolutions Inc.
2017
FIFTH AMENDMENT, LIMITED WAIVER AND CONSENT TO CREDIT AGREEMENT
Credit Agreements
Emergent BioSolutions Inc.
2017
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
Emergent BioSolutions Inc.
2017
FOURTH AMENDED AND RESTATED EMERGENT BIOSOLUTIONS INC. 2006 STOCK INCENTIVE PLAN
Bonus & Incentive Agreements
Emergent BioSolutions Inc.
Biotechnology
DE
2016
CONSULTING AGREEMENT
Consulting Agreements
Emergent BioSolutions Inc.
2016
SEPARATION AND DISTRIBUTION AGREEMENT BY AND BETWEEN EMERGENT BIOSOLUTIONS INC. AND APTEVO THERAPEUTICS INC. DATED AS OF JULY 29, 2016
Separation Agreements
Emergent BioSolutions Inc.
Biotechnology
DE
2016
CONSULTING AGREEMENT
Consulting Agreements
Emergent BioSolutions Inc.
Biotechnology
NY
2016
CONSULTING AGREEMENT
Consulting Agreements
Emergent BioSolutions Inc.
Biotechnology
NY
2016
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
Emergent BioSolutions Inc.
2016
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
Emergent BioSolutions Inc.
2016
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. AMENDMENT OF SOLICITATION/MODIFICATION OF...
Emergent BioSolutions Inc.
Biotechnology
2016
THIRD AMENDMENT TO CREDIT AGREEMENT
Credit Agreements
Emergent BioSolutions Inc.
Biotechnology
NY
2015
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
Emergent BioSolutions Inc.
2015
SECOND AMENDMENT TO CREDIT AGREEMENT
Credit Agreements
Emergent BioSolutions Inc.
Biotechnology
NY
2014
FIRST AMENDMENT TO CREDIT AGREEMENT
Credit Agreements
Emergent BioSolutions Inc.
Biotechnology
NY
2014
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
Emergent BioSolutions Inc.
2014
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
Emergent BioSolutions Inc.
2014
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
Emergent BioSolutions Inc.
2013
Confidential Materials omitted and filed separately with theSecurities and Exchange Commission. Double asterisks denote omissions. PAGE 2The purpose of this modification is to...
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2013
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions
Emergent BioSolutions Inc.
2013
FOURTH AMENDMENT TO LEASE AGREEMENT
Lease Agreements
Emergent BioSolutions Inc.
2013
FIFTH AMENDMENT TO LEASE AGREEMENT
Lease Agreements
Emergent BioSolutions Inc.
Biotechnology
2013
Emergent BioSolutions Inc. Form of Director Nonstatutory Stock Option Agreement Granted Under the Second Amended and Restated 2006 Stock Incentive Plan
Bonus & Incentive Agreements
Emergent BioSolutions Inc.
2013
EMERGENT BIOSOLUTIONS INC. Form of Director Restricted Stock Unit Agreement Second Amended and Restated 2006 Stock Incentive Plan
Bonus & Incentive Agreements
Emergent BioSolutions Inc.
Biotechnology
DE
2013
Form of Restricted Stock Unit Award
Stock Agreements
Emergent BioSolutions Inc.
2013
Amended and Restated Board Compensation Program for Outside Directors Effective May 19, 2011
Compensation Agreements
Emergent BioSolutions Inc.
Biotechnology
2013
SECOND AMENDMENT TO LOAN DOCUMENTS
Loan Agreements
Emergent BioSolutions Inc.
2012
PAGE OF PAGES 12
Emergent BioSolutions Inc.
2012
PAGE OF PAGES 1 3
Emergent BioSolutions Inc.
Biotechnology
2012
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.
Emergent BioSolutions Inc.
2012
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.
Emergent BioSolutions Inc.
2012
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.
Emergent BioSolutions Inc.
2012
FIRST AMENDMENT TO LOAN DOCUMENTS
Loan Agreements
Emergent BioSolutions Inc.
Biotechnology
2012
Amendment to Loan Documents
Loan Agreements
Emergent BioSolutions Inc.
Biotechnology
2012
Temperature Range
Emergent BioSolutions Inc.
2012
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.
Emergent BioSolutions Inc.
Biotechnology
MD
2012
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.
Emergent BioSolutions Inc.
2012
SECOND AMENDMENT TO LEASE AGREEMENT
Lease Agreements
Emergent BioSolutions Inc.
Biotechnology
DE
2012
FIRST AMENDMENT TO LEASE AGREEMENT
Lease Agreements
Emergent BioSolutions Inc.
2012
Execution CopyExhibit 10.47 THIRD AMENDMENT TO LEASE AGREEMENT
Lease Agreements
Emergent BioSolutions Inc.
2012
Emergent BioSolutions Inc. Amended and Restated Senior Management Severance Plan
Severance Agreements
Emergent BioSolutions Inc.
2011
Emergent BioSolutions Inc. Senior Management Severance Plan
Severance Agreements
Emergent BioSolutions Inc.
2011
Construction Loan Agreement
Loan Agreements
Emergent BioSolutions Inc.
2011
[BALANCE OF PAGE INTENTIONALLY LEFT BLANK SIGNATURE PAGE TO FOLLOW]
Emergent BioSolutions Inc.
Biotechnology
MD
2011
DEPARTMENT OF HEALTH & HUMAN SERVICES
Emergent BioSolutions Inc.
2011
Confidential Materials omitted and filed separately with the Securities and Exchange Commission.Asterisks denote omissions.
Emergent BioSolutions Inc.
Biotechnology
NY
2011
CONSULTING SERVICES AGREEMENT
Consulting Agreements
Emergent BioSolutions Inc.
Biotechnology
NY
2011
SEGRO (WINNERSH) LIMITED (1) EMERGENT PRODUCT DEVELOPMENT UK LIMITED (2) DEED OF SURRENDER relating to Units 545 Winnersh Triangle, Wokingham, Berkshire
Development Agreements
Emergent BioSolutions Inc.
Biotechnology
2011
Exhibit 10.1 February 17, 2011 Greg SiegristPresidentEast West Resources Corporation12001 Glen RoadPotomac, MD 20854Re:Services Agreement with Emergent BioSolutions Inc.Dear Mr....
Exchange Agreements
Emergent BioSolutions Inc.
Biotechnology
2011
SUPPLY AGREEMENT
Supply Agreements
Emergent BioSolutions Inc.
Biotechnology
WA
2011
AGREEMENT AND PLAN OF MERGER
Merger Agreements
Emergent BioSolutions Inc.
2010
CONTINGENT VALUE RIGHTS AGREEMENT
Emergent BioSolutions Inc.
2010
CONSULTING AGREEMENT
Consulting Agreements
Emergent BioSolutions Inc.
2010
* * * * *
Emergent BioSolutions Inc.
Biotechnology
MD
2010
Amended and Restated Board Compensation Program for Outside Directors Effective May 20, 2010
Compensation Agreements
Emergent BioSolutions Inc.
2010
CONSULTINGSERVICES AGREEMENT
Emergent BioSolutions Inc.
Biotechnology
NY
2010
EMERGENTBIOSOLUTIONS INC. Restricted Stock UnitAgreement Amendedand Restated 2006 Stock Incentive Plan
Bonus & Incentive Agreements
Emergent BioSolutions Inc.
Biotechnology
DE
2010
ANNUALBONUS PLAN FOR EXECUTIVE OFFICERS EMERGENTBIOSOLUTIONS INC. ADOPTEDFEBRUARY 25, 2010
Emergent BioSolutions Inc.
Biotechnology
2010
CONFIDENTIAL MATERIALS OMITTED AND FILED SEPERATLY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISK DENOTE OMISSIONS. Talecris BIOTHERAPEUTICS AMENDMENTNO. 1 to the...
Exchange Agreements
Emergent BioSolutions Inc.
2010
Talecris BIOTHERAPEUTICS AMENDMENTNO. 2 to the ProductSupply Agreement
Emergent BioSolutions Inc.
Biotechnology
NY
2010
CONFIDENTIAL MATERIALS OMITTED AND FILED SEPERATLY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISK DENOTE OMISSIONS. Talecris BIOTHERAPEUTICS AMENDMENTNO. 3 to the...
Exchange Agreements
Emergent BioSolutions Inc.
Biotechnology
NY
2010
CONFIDENTIAL MATERIALS OMITTED AND FILED SEPERATLY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISK DENOTE OMISSIONS. Talecris BIOTHERAPEUTICS FirstAddendum to ProductSupply...
Exchange Agreements
Emergent BioSolutions Inc.
Biotechnology
NY
2010
PROMISSORYNOTE (TermNote)
Emergent BioSolutions Inc.
Biotechnology
MD
2010
EMERGENT BIOSOLUTIONS INC.
Emergent BioSolutions Inc.
2006
RIGHTS AGREEMENT between EMERGENT BIOSOLUTIONS INC. and AMERICAN STOCK TRANSFER & TRUST COMPANY, as Rights Agent Dated , 2006
Registration Rights Agreements
Emergent BioSolutions Inc.
2006
EMERGENT BIOSOLUTIONS INC.
Emergent BioSolutions Inc.
2006
Emergent BioSolutions Inc.
Emergent BioSolutions Inc.
2006
Emergent BioSolutions Inc.
Emergent BioSolutions Inc.
2006
CLASS A STOCKHOLDERS REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
Emergent BioSolutions Inc.
2006
AMENDED AND RESTATED MARKETING AGREEMENT
Marketing Agreements
Emergent BioSolutions Inc.
2006
LEASE AGREEMENT BRANDYWINE RESEARCH LLC Landlord and EMERGENT BIOSOLUTIONS INC. Tenant 2273 Research Boulevard Rockville, Maryland 20850 Dated: June 27, 2006
Lease Agreements
Emergent BioSolutions Inc.
2006
SERVICES AGREEMENT
Services Agreements
Emergent BioSolutions Inc.
2006
Amended and Restated Board Compensation Program
Compensation Agreements
Emergent BioSolutions Inc.
2006
PROMISSORY NOTE $8,500,000.00 April 25th, 2006
Note Agreements
Emergent BioSolutions Inc.
2006
LOAN AGREEMENT
Loan Agreements
Emergent BioSolutions Inc.
2006
PROMISSORY NOTE
Note Agreements
Emergent BioSolutions Inc.
2006
PROMISSORY NOTE (Revolving Credit Loan) $5,000,000.00 August 25, 2006
Loan Agreements
Emergent BioSolutions Inc.
2006
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
Emergent BioSolutions Inc.
2006
EMERGENT BIOSOLUTIONS INC. EMPLOYEE STOCK OPTION PLAN (as amended and restated effective January 26, 2005)
Stock Agreements
Emergent BioSolutions Inc.
2006
EMERGENT BIOSOLUTIONS INC. DIRECTOR STOCK OPTION AGREEMENT
Stock Agreements
Emergent BioSolutions Inc.
2006
INDEMNITY AGREEMENT
Emergent BioSolutions Inc.
2006
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.
Emergent BioSolutions Inc.
2006
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.
Emergent BioSolutions Inc.
2006
FILLING SERVICES AGREEMENT
Services Agreements
Emergent BioSolutions Inc.
2006
Confidential Materials omitted and filed separately with the Securites and Exchange Commission. Asterisks denote omissions. BT VACCINE LICENSE AGREEMENT
Exchange Agreements
Emergent BioSolutions Inc.
2006
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.
Emergent BioSolutions Inc.
2006
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.
Emergent BioSolutions Inc.
2006
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.
Emergent BioSolutions Inc.
2006
AMENDED AND RESTATED MARKETING AGREEMENT
Marketing Agreements
Emergent BioSolutions Inc.
2006
LEASE
Lease Agreements
Emergent BioSolutions Inc.
2006
AMENDED AND RESTATED LOAN AGREEMENT
Loan Agreements
Emergent BioSolutions Inc.
2006
LOAN AND SECURITY AGREEMENT
Loan Agreements
Emergent BioSolutions Inc.
2006
PROMISSORY NOTE $7,000,000.00 October 14, 2004
Note Agreements
Emergent BioSolutions Inc.
2006
LOAN AGREEMENT
Loan Agreements
Emergent BioSolutions Inc.
2006
DEED OF TRUST NOTE
Note Agreements
Emergent BioSolutions Inc.
2006
LOAN AGREEMENT
Loan Agreements
Emergent BioSolutions Inc.
2006
COUNTY COMMISSIONERS OF FREDERICK COUNTY, EMERGENT BIOLOGICS INC. a n d MERCANTILE POTOMAC BANK BOND PURCHASE AGREEMENT Dated as of March 31, 2005 Frederick County, Maryland Tax...
Purchase Agreements
Emergent BioSolutions Inc.
2006
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.
Emergent BioSolutions Inc.
2006
Modification No. 20, effective January 7, 2020, to the CDC BioThrax Procurement Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2020
Modification No. 9, effective June 6, 2018, to the Solicitation/Contract/Order for Commercial Items, effective December 8, 2016, from the Centers for Disease Control and...
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2018
Modification No. 2
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2018
Modification No. 3
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2018
REMAINDER OF PAGE INTENTIONALLY LEFT BLANK
Emergent BioSolutions Inc.
Biotechnology
2011
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.
Emergent BioSolutions Inc.
Biotechnology
2011
Confidential Materials omitted and filed separately with the Securities and Exchange Commission.Asterisks denote omissions. WYETH LLC ACTING THROUGH ITS WYETH PHARMACEUTICALS...
Emergent BioSolutions Inc.
Biotechnology
2011
CONTENTS
Emergent BioSolutions Inc.
Biotechnology
2011
CONTENTS
Emergent BioSolutions Inc.
Biotechnology
2011
DATED17 May 2011
Emergent BioSolutions Inc.
Biotechnology
2011
SUPPORT AGREEMENT
Emergent BioSolutions Inc.
Biotechnology
DE
2010
Very truly yours, ARCH Venture Fund V, L.P. By: ARCH Venture Partners V, L.P. Its: General Partner By: ARCH Venture Partners V, L.L.C. Its: General Partner By: Name: Its: Managing...
Emergent BioSolutions Inc.
Biotechnology
2010
Talecris BIOTHERAPEUTICS AmendmentNo. 4 to ProductSupply Agreement
Emergent BioSolutions Inc.
Biotechnology
NY
2010
CONSULTINGSERVICES AGREEMENT
Emergent BioSolutions Inc.
Biotechnology
NY
2010
LOANAGREEMENT
Emergent BioSolutions Inc.
Biotechnology
MD
2010
By: /s/ Fuad El-Hibri Title: CEO By: Title:
Emergent BioSolutions Inc.
2006
/s/ Fuad El-Hibri 8/9/06 Fuad El-Hibri Dated
Emergent BioSolutions Inc.
2006
Schedule 3.3
Emergent BioSolutions Inc.
2006
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.
Emergent BioSolutions Inc.
2006
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.
Emergent BioSolutions Inc.
2006
ConfidentialMaterials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.
Emergent BioSolutions Inc.
2006
Signed: /s/ Fuad El-Hibri Fuad El-Hibri, Chairman of the Board
Emergent BioSolutions Inc.
2006
July 11, 2006 Emergent BioSolutions Inc. 300 Professional Drive, Suite 250 Gaithersburg. MD 20879 ###-###-#### f ###-###-#### www.emergentbiosolutions.comDr. Steven Chatfield 31,...
Emergent BioSolutions Inc.
2006
DATED 13th December 1996
Emergent BioSolutions Inc.
2006
DATED 13th December 1996
Emergent BioSolutions Inc.
2006
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.
Emergent BioSolutions Inc.
2006